From: Vapoenucleation of the prostate using a high-power thulium laser: a one-year follow-up study
Characteristic | ThuVEP | TURP | p |
---|---|---|---|
Number | 29 | 30 | |
Age (years) | 76.1 ± 9.4 | 72.6 ± 7.4 | 0.280 |
Anticoagulant* | 15(51.7%) | 6(20.0%) | 0.011 |
BMI | 23.9 ± 2.7 | 23.7 ± 3.4 | 0.281 |
PSA (ng/mL) | 5.0 ± 5.4 | 8.3 ± 7.9 | 0.076 |
TRUS estimated weight (g) | 57.2 ± 25.1 | 64.7 ± 32.5 | 0.758 |
IPSS | 17.1 ± 5.0 | 17.8 ± 4.3 | 0.674 |
Charlson co-morbidity index | 1.0 ± 1.0 | 1.6 ± 2.7 | 0.639 |
Qmax (mL/s) | 10.5 ± 4.9 | 10.8 ± 4.7 | 0.728 |
PVR vol (mL)* | 138.6 ± 127.7 | 90.9 ± 66.5 | 0.040 |